Page last updated: 2024-11-06

methyl 2-tetradecylglycidate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl 2-tetradecylglycidate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68593
CHEMBL ID12261
SCHEMBL ID243423
MeSH IDM0068333

Synonyms (38)

Synonym
69207-52-9
nsc-359682
nsc359682
methyl palmoxirate
methyl (+-)-2-tetradecylglycidate
mcn 3716
2-oxiranecarboxylic acid, 2-tetradecyl-, methyl ester
2-tetradecyl-2-oxiranecarboxylic acid methyl ester
methyl palmoxirate [usan]
mcn-3716
oxiranecarboxylic acid, 2-tetradecyl-, methyl ester, (+-)-
methyl 2-tetradecyloxiranecarboxylate
methyl palmoxirate (usan)
D04992
CHEMBL12261 ,
methyl 2-tetradecyloxirane-2-carboxylate
92982-25-7
bdbm50024433
2-tetradecyl-oxirane-2-carboxylic acid methyl ester
(+/-) 2-tetradecyl-oxirane-2-carboxylic acid methyl ester
nsc 359682
unii-npl6006y4b
methyl 2-tetradecylglycidate
npl6006y4b ,
SCHEMBL243423
oxiranecarboxylic acid, 2-tetradecyl-, methyl ester, (+/-)-
methyl tetradecylglycidate
methyl 2-tetradecyl-2-oxiranecarboxylate #
HY-U00159
mcn3716
CS-7213
DTXSID10918804
methyl palmoxirate;mcn3716;methyl 2-tetradecylglycidate;mcn 3716; nsc359682
BCP30486
methyl palmoxirate; nsc359682
Q27284987
MS-24298
AKOS040733698

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results emphasize the need for pilot toxicity studies, especially when components of the test system are varied, to assess the effect of drug concentration on the toxic response."( Alterations of drug-induced toxicity in the mouse lymphoma assay by a rat hepatic microsomal metabolizing system (S-9).
Oldham, JW; Paulson, JD; Preston, RF; Pritchard, JF, 1984
)
0.27

Pharmacokinetics

ExcerptReferenceRelevance
" As it is essential to pretreat human subjects with an acute dose of MEP prior to intravenous injection of [1-11C]palmitate for PET scanning, this study was undertaken to determine the plasma elimination half-life of MEP in rats and human subjects and to provide insight about the drug's absorption and metabolism."( Pharmacokinetics of methyl palmoxirate, an inhibitor of beta-oxidation, in rats and humans.
Chang, MC; Connolly, C; Grimes, G; Hayakawa, T; Hill, D; Purdon, AD; Shetty, HU, 1998
)
0.3

Dosage Studied

ExcerptRelevanceReference
" The energy content of this lipid lost during the 4-h period after dosing was equivalent to approximately 50% of the thermogenic effect of the compound over the same period, suggesting that lipid stored in brown adipose tissue is a major initial fuel for BRL 26830A induced thermogenesis."( Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A.
Arch, JR; Thurlby, PL; Wilson, S, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)IC50 (µMol)0.30000.00051.48357.8000AID46869
Carnitine O-palmitoyltransferase 1, liver isoform Rattus norvegicus (Norway rat)IC50 (µMol)0.09000.04000.06500.0900AID219026
Carnitine palmitoyl transferase I liver isoform Sus scrofa (pig)IC50 (µMol)0.30000.30000.60000.9000AID46869
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID194314Rat glucose tolerance test was determined in vivo at 75 mg/kg perorally1987Journal of medicinal chemistry, Jun, Volume: 30, Issue:6
Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.
AID184857Minimum effective concentration by rat glucose tolerance test (po)1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Alkylglycidic acids: potential new hypoglycemic agents.
AID719787Reduction in blood glucose in fed db/db mouse at 50 to 100 mg/kg, po measured 2 to 4 hrs post dose2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID219026Inhibition of carnitine palmitoyl transferase (CPT), assessed with isolated rat liver mitochondria1987Journal of medicinal chemistry, Jun, Volume: 30, Issue:6
Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.
AID719783Suppression of labeled pyruvate conversion to [14C]glucose in Sprague-Dawley rat at 10 to 20 mg/kg, po2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID185057Rat glucose tolerance in vivo expressed as minimum effective dose (MED), it is the lowest dose giving a statistically significant (p<0.05) lowering at any time point1987Journal of medicinal chemistry, Jun, Volume: 30, Issue:6
Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.
AID184484Compound was tested in vitro for inhibition of palmitate oxidation1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Alkylglycidic acids: potential new hypoglycemic agents.
AID179589In vitro inhibition of [1-14C]palmitate oxidation in rat hemidiaphragms1987Journal of medicinal chemistry, Jun, Volume: 30, Issue:6
Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.
AID719781Reduction in fasting glucose in STZ-treated dog at 2.5 mg/kg/day, po for 7 days2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719782Reduction in KB level in in alloxan-treated rat at 25 to 50 mg/kg, po measured 2 to 5 hrs post dose2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID186048Maximum lowering of blood glucose when 75 mg/kg of the drug administered orally was reported by rat glucose tolerance test1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Alkylglycidic acids: potential new hypoglycemic agents.
AID719619Inhibition of carnitine palmitoyltransferase in rat liver mitochondria assessed as formation of formation of palmitoyl[3H]carnitine from palmitoyl-CoA and [3H]carnitine2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID46869Compound was tested for its inhibitory activity against carnitine palmitoyl transferase-A (CPT-A)1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Alkylglycidic acids: potential new hypoglycemic agents.
AID719620Inhibition of carnitine palmitoyltransferase hemidiaphragms isolated from fasted pretreated rat assessed as reduction of [14]CO2 production from [1-14]-palmitate or [14C]-oleate2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719780Reduction in blood glucose in STZ-treated dog at 0.7 to 2 mg/kg/day, po for 7 days measured 6 hrs post dose (Rvb = 9 mM)2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719779Reduction in blood glucose in alloxan -treated dog at 7.5 mg/kg, po administered as single dose measured 6 hrs post dose (Rvb = 9 mM)2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID179249In vitro inhibition of palmitate oxidation1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Alkylglycidic acids: potential new hypoglycemic agents.
AID719786Reduction in blood glucose in fasted db/db mouse at 50 to 100 mg/kg, po measured 2 to 4 hrs post dose2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (74)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (36.49)18.7374
1990's34 (45.95)18.2507
2000's11 (14.86)29.6817
2010's2 (2.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.86 (24.57)
Research Supply Index4.33 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.33%)6.00%
Case Studies1 (1.33%)4.05%
Observational0 (0.00%)0.25%
Other73 (97.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]